Summary
Nasdaq, Inc. (NDAQ) filed an 8-K/A amendment on January 17, 2024, primarily to furnish investors with a presentation detailing the historical financial results of Adenza. This presentation, made available on Nasdaq's investor relations website, includes information previously undisclosed and will be utilized for investor meetings and general marketing. The filing also incorporates key financial statements related to the Adenza acquisition. Specifically, the amendment includes audited consolidated financial statements for Adenza for the fiscal years 2022 and 2021, as well as unaudited statements for the nine and three-month periods ending September 30, 2023, and 2022. Furthermore, pro forma condensed combined financial information as of September 30, 2023, and for the year ended December 31, 2022, and the interim period ended September 30, 2023, is provided. This comprehensive financial disclosure is crucial for investors to assess the financial impact and performance of the Adenza acquisition.
Key Highlights
- 1Nasdaq posted a presentation of Adenza's historical financial results on January 17, 2024, on its investor relations website.
- 2The presentation includes previously non-public information for investor meetings and marketing.
- 3Audited consolidated financial statements of Adenza for FY 2022 and 2021 are now available.
- 4Unaudited consolidated financial statements for Adenza for the nine and three months ended September 30, 2023, and 2022, are included.
- 5Pro forma condensed combined financial information for the combined company as of September 30, 2023, and for relevant periods is provided.
- 6This filing supplements information related to the Adenza acquisition.